Garnet Health Medical Center is a Middletown, New York-based three-campus hospital which, together with its nine urgent-care facilities, "provides care to approximately 450,000 residents in Orange, Sullivan and Ulster counties" in New York State. The hospital's roots date back to 1887.

During the past decade, Garnet Health Medical Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 21 clinical trials were completed, i.e. on average, 110.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 12 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Garnet Health Medical Center" #1 collaborator was "NRG Oncology" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Garnet Health Medical Center" are "Stage IIA Breast Cancer AJCC v6 and v7" (5 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (5 trials), "Stage IIIA Breast Cancer AJCC v7" (4 trials), "Recurrent Lung Non-Small Cell Carcinoma" (3 trials) and "Stage IB Breast Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Garnet Health Medical Center" in a lesser frequency.

Most popular intervention types in "Garnet Health Medical Center" are "Drug" (34 trials), "Other" (29 trials), "Biological" (25 trials), "Radiation" (11 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (11 trials), "Bevacizumab" (9 trials), "Carboplatin" (7 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Garnet Health Medical Center" are 32 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Garnet Health Medical Center". undefined are not yet recruiting, 6 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Garnet Health Medical Center, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Garnet Health Medical Center, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".